The ACIP now recommends all adults 19-59 and adults >59 with risk factors be vaccinated for Hep B.
There are currently four approved adult Hep B vaccines on the market:
- GSK Engerix-B
- Merck Recombivax HB
- Dynavax Heplisav-B
- VBI Vaccines PreHevbrio
To read more about the April 2022 ACIP recommendations, please click here.